rs79493678

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024312.5(GNPTAB):​c.3602+8C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0382 in 1,608,380 control chromosomes in the GnomAD database, including 1,412 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 90 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1322 hom. )

Consequence

GNPTAB
NM_024312.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0003069
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.346

Publications

11 publications found
Variant links:
Genes affected
GNPTAB (HGNC:29670): (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010]
GNPTAB Gene-Disease associations (from GenCC):
  • GNPTAB-mucolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mucolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • mucolipidosis type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • mucolipidosis type III, alpha/beta
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-101753364-G-T is Benign according to our data. Variant chr12-101753364-G-T is described in ClinVar as Benign. ClinVar VariationId is 96122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0288 (4375/151848) while in subpopulation NFE AF = 0.0461 (3136/68000). AF 95% confidence interval is 0.0448. There are 90 homozygotes in GnomAd4. There are 2068 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 90 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024312.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNPTAB
NM_024312.5
MANE Select
c.3602+8C>A
splice_region intron
N/ANP_077288.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNPTAB
ENST00000299314.12
TSL:1 MANE Select
c.3602+8C>A
splice_region intron
N/AENSP00000299314.7Q3T906-1
GNPTAB
ENST00000917136.1
c.3623+8C>A
splice_region intron
N/AENSP00000587195.1
GNPTAB
ENST00000917134.1
c.3596+8C>A
splice_region intron
N/AENSP00000587193.1

Frequencies

GnomAD3 genomes
AF:
0.0289
AC:
4378
AN:
151728
Hom.:
90
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00652
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.0178
Gnomad ASJ
AF:
0.0311
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.0448
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0461
Gnomad OTH
AF:
0.0277
GnomAD2 exomes
AF:
0.0325
AC:
8157
AN:
251282
AF XY:
0.0327
show subpopulations
Gnomad AFR exome
AF:
0.00674
Gnomad AMR exome
AF:
0.0184
Gnomad ASJ exome
AF:
0.0258
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0491
Gnomad NFE exome
AF:
0.0502
Gnomad OTH exome
AF:
0.0368
GnomAD4 exome
AF:
0.0392
AC:
57109
AN:
1456532
Hom.:
1322
Cov.:
30
AF XY:
0.0384
AC XY:
27853
AN XY:
724966
show subpopulations
African (AFR)
AF:
0.00579
AC:
192
AN:
33144
American (AMR)
AF:
0.0177
AC:
789
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0271
AC:
706
AN:
26098
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39646
South Asian (SAS)
AF:
0.00547
AC:
471
AN:
86150
European-Finnish (FIN)
AF:
0.0493
AC:
2634
AN:
53400
Middle Eastern (MID)
AF:
0.0335
AC:
193
AN:
5754
European-Non Finnish (NFE)
AF:
0.0454
AC:
50252
AN:
1107464
Other (OTH)
AF:
0.0311
AC:
1871
AN:
60190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2425
4850
7275
9700
12125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1736
3472
5208
6944
8680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0288
AC:
4375
AN:
151848
Hom.:
90
Cov.:
33
AF XY:
0.0279
AC XY:
2068
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.00648
AC:
267
AN:
41220
American (AMR)
AF:
0.0178
AC:
272
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0311
AC:
108
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4820
European-Finnish (FIN)
AF:
0.0448
AC:
473
AN:
10560
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0461
AC:
3136
AN:
68000
Other (OTH)
AF:
0.0274
AC:
58
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
215
431
646
862
1077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0391
Hom.:
65
Bravo
AF:
0.0261
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0420
EpiControl
AF:
0.0438

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
Mucolipidosis type II (3)
-
-
3
not specified (3)
-
-
2
Pseudo-Hurler polydystrophy (2)
-
-
1
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.44
DANN
Benign
0.51
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00031
dbscSNV1_RF
Benign
0.054
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79493678; hg19: chr12-102147142; COSMIC: COSV107340415; COSMIC: COSV107340415; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.